QuickView for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=86A2AA8A39E51C0F450049D37E597C04;jsessionid=21CC80C537D5EC279C3D3E4646FC0D2E;jsessionid=9F23DE39F78146975DEB8DE90D46D1CD;jsessionid=FC515D6A16AEDC64F45C11CCF22C9265 (gene)

1. Thymic stroma and TFII-I: towards new targeted therapies.
2. Proteomic analysis of SRF associated transcription complexes identified TFII-I as modulator of SRF f…
3. Structural basis for evolutionarily conserved interactions between TFIIS and Paf1C.
4. The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and dis…
5. Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII.

There were no clinical trials for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=86A2AA8A39E51C0F450049D37E597C04;jsessionid=21CC80C537D5EC279C3D3E4646FC0D2E;jsessionid=9F23DE39F78146975DEB8DE90D46D1CD;jsessionid=FC515D6A16AEDC64F45C11CCF22C9265